Efficacy of ondanstron in the treatment of schizophrenia
Phase 2
Recruiting
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT20180505039530N1
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Ages of subjects were between 25 to 65 years
Is based on DSM-IV diagnosis of schizophrenia
The patient or patient's guardian consent to participate.
PANSS score at the beginning of the project is more than 55.
Exclusion Criteria
Patients treated with clozapine
Pregnancy and breast feeding
Any serious medical or neurological problem
Hypersensitivity to ondansetron
Substance abuse and alcohol
Patients who choose to be excluded.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of schizophrenia. Timepoint: The beginning of the study and 4, 8, 12 months after beginning of treatment. Method of measurement: Positive and Negative Syndrome Scale (PANSS).
- Secondary Outcome Measures
Name Time Method